Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Avidity Biosciences Inc (RNA)

Avidity Biosciences Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,597,368
  • Shares Outstanding, K 109,801
  • Annual Sales, $ 9,560 K
  • Annual Income, $ -212,220 K
  • EBIT $ -285 M
  • EBITDA $ -294 M
  • 60-Month Beta 0.91
  • Price/Sales 485.38
  • Price/Cash Flow N/A
  • Price/Book 3.80

Options Overview Details

View History
  • Implied Volatility 81.18% ( +0.44%)
  • Historical Volatility 65.40%
  • IV Percentile 40%
  • IV Rank 30.49%
  • IV High 161.97% on 11/16/23
  • IV Low 45.74% on 11/10/23
  • Put/Call Vol Ratio 1.09
  • Today's Volume 73
  • Volume Avg (30-Day) 267
  • Put/Call OI Ratio 0.88
  • Today's Open Interest 10,741
  • Open Int (30-Day) 10,036

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.78
  • Number of Estimates 4
  • High Estimate -0.56
  • Low Estimate -0.94
  • Prior Year -0.71
  • Growth Rate Est. (year over year) -9.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
41.12 +9.00%
on 11/04/24
50.78 -11.74%
on 10/18/24
-2.48 (-5.24%)
since 10/04/24
3-Month
37.04 +21.00%
on 08/05/24
50.78 -11.74%
on 10/18/24
+3.55 (+8.60%)
since 08/02/24
52-Week
5.15 +770.29%
on 11/10/23
50.78 -11.74%
on 10/18/24
+39.35 (+719.38%)
since 11/03/23

Most Recent Stories

More News
2 Promising Growth Stocks to Buy and Hold for a Decade or Longer

These two growth stocks could be great additions to a long-term buy-and-hold portfolio.

RNA : 44.82 (+7.05%)
$SPX : 5,712.69 (-0.28%)
LLY : 806.14 (-1.56%)
UBER : 73.25 (unch)
CART : 44.64 (-0.30%)
BMY : 55.45 (+2.08%)
Why Avidity Biosciences Zoomed to a 12% Gain This Week

The company's most promising pipeline program can continue unabated.

RNA : 44.82 (+7.05%)
GS : 511.47 (-1.52%)
Stocks Pressured by Middle East Risks

The S&P 500 Index ($SPX ) (SPY ) today is down by -0.23%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.15%. Stocks today are...

NVDA : 136.05 (+0.48%)
CEG : 225.95 (-12.46%)
RNA : 44.82 (+7.05%)
$SPX : 5,712.69 (-0.28%)
ADI : 224.19 (-0.57%)
HIMS : 20.76 (+1.96%)
NXPI : 236.90 (-0.71%)
TSCO : 270.36 (+1.42%)
LUV : 29.91 (-2.29%)
ACN : 343.90 (-0.51%)
$IUXX : 19,963.60 (-0.35%)
STM : 25.96 (-2.66%)
2 Standout Biotech Stocks With 32% to 63% Upside

A strong pipeline of products could potentially transform these companies, but there are risks.

RNA : 44.82 (+7.05%)
$SPX : 5,712.69 (-0.28%)
BMY : 55.45 (+2.08%)
VRNA : 38.15 (+9.06%)
3 Russell 2000 Growth Stocks That Could Be Worth the Risk

These three small-cap stocks could deliver hefty returns if the central bank cuts rates.

LBPH : 59.50 (-0.32%)
RNA : 44.82 (+7.05%)
SOUN : 5.09 (-0.97%)
Avidity Biosciences (RNA) Stock Surges on Positive AOC 1020 Trial Results

Avidity Biosciences (NASDAQ: RNA) has seen a significant surge in its stock price, opening nearly 5% higher today. This increase comes following impressive results from Avidity’s AOC 1020 clinical trial...

RNA : 44.82 (+7.05%)
Chart of the Day: Avidity Biosciences --- Something's Up???

Author's Note: Every once in a while I see a stock where most analysts predict decreasing Revenue and Earnings but they all seem to recommend it anyway — Here is a good example. Please tell my what...

RNA : 44.82 (+7.05%)
Oracle, Casey's General Stores rise; Vera Bradley, PetMed fall, Wednesday, 6/12/2024

Stocks that traded heavily or had substantial price changes on Wednesday: Oracle, Casey’s General Stores rise; Vera Bradley, PetMed fall

FCX : 46.27 (+1.49%)
RNA : 44.82 (+7.05%)
PETS : 4.22 (+0.72%)
PARAA : 21.97 (+0.87%)
VRA : 5.07 (+0.60%)
CASY : 381.08 (-3.08%)
ORCL : 169.59 (-0.25%)
2 Potentially High-Reward Growth Stocks to Buy Right Now

These two biotechnology stocks could be gearing up for a run.

RNA : 44.82 (+7.05%)
LRMR : 7.57 (-2.20%)
5 Breakout Biotech Stocks Leading the Russell 2000 Higher

These small-cap biotech stocks are rallying hard in 2024, and still have room to keep leading the RUT higher.

JANX : 55.87 (+2.72%)
VKTX : 63.14 (-13.36%)
LBPH : 59.50 (-0.32%)
ARQT : 8.72 (+0.58%)
RNA : 44.82 (+7.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Avidity Biosciences Inc. is a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates(TM). The company's AOC platform design, engineer and develop therapeutics which combine the tissue selectivity of monoclonal antibodies and the...

See More

Key Turning Points

3rd Resistance Point 51.03
2nd Resistance Point 48.31
1st Resistance Point 46.56
Last Price 44.82
1st Support Level 42.10
2nd Support Level 39.38
3rd Support Level 37.63

See More

52-Week High 50.78
Last Price 44.82
Fibonacci 61.8% 33.35
Fibonacci 50% 27.97
Fibonacci 38.2% 22.58
52-Week Low 5.15

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar